Found: 43
Select item for more details and to access through your institution.
Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
improved molecular inversion probe based targeted sequencing approach for low variant allele frequency.
- Published in:
- NAR Genomics & Bioinformatics, 2022, v. 4, n. 1, p. 1, doi. 10.1093/nargab/lqab125
- By:
- Publication type:
- Article
Biallelic disruption of DDX41 activity is associated with distinct genomic and immunophenotypic hallmarks in acute leukemia.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1153082
- By:
- Publication type:
- Article
Acute myeloid leukaemia relapse after allogeneic haematopoietic stem cell transplantation: Mechanistic diversity and therapeutic directions.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 5, p. 722, doi. 10.1111/bjh.19121
- By:
- Publication type:
- Article
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment‐free remission after failing the first attempt with imatinib: Treatment‐free Remission Accomplished by Dasatinib (TRAD) study.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 5, p. 781, doi. 10.1111/bjh.19058
- By:
- Publication type:
- Article
BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 1, p. 136, doi. 10.1111/bjh.17807
- By:
- Publication type:
- Article
Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 3, p. 1011, doi. 10.4143/crt.2022.1407
- By:
- Publication type:
- Article
Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 3, p. 789, doi. 10.1007/s00277-020-04363-1
- By:
- Publication type:
- Article
Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 6, p. 955, doi. 10.1007/s00277-018-3260-6
- By:
- Publication type:
- Article
Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5543, doi. 10.3390/cancers13215543
- By:
- Publication type:
- Article
DNA Sequencing in Adults With Acute Myeloid Leukemia to Detect Residual Disease Prior to Hematopoietic Cell Transplant.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 2, p. 190, doi. 10.1001/jama.2023.8650
- By:
- Publication type:
- Article
Late‐onset Pneumocystis jirovecii pneumonia post‐allogeneic stem cell transplantation after time‐dependent discontinuation of prophylaxis.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 433, doi. 10.1111/ejh.14133
- By:
- Publication type:
- Article
Prognostic implication of pre-transplant FEV<sub>1</sub> on long-term outcomes following allogeneic hematopoietic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 5, p. 687, doi. 10.1111/ejh.14062
- By:
- Publication type:
- Article
Refined hepatic grading system in chronic graft‐versus‐host disease improves prognostic risk stratification of long‐term outcomes.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 508, doi. 10.1111/ejh.13576
- By:
- Publication type:
- Article
Prolactin, a potential biomarker for chronic GVHD activity.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 2, p. 158, doi. 10.1111/ejh.13531
- By:
- Publication type:
- Article
Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 1, p. 32, doi. 10.1111/ejh.13482
- By:
- Publication type:
- Article
Outcomes of therapy‐related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 24, doi. 10.1111/ejh.13403
- By:
- Publication type:
- Article
A Comparison of Long-Term Outcomes of Donor Lymphocyte Infusions and Tyrosine Kinase Inhibitors in Patients With Relapsed CML After Allogeneic Hematopoietic Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2014, v. 14, n. 1, p. 87, doi. 10.1016/j.clml.2013.09.010
- By:
- Publication type:
- Article
Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 1, p. 36, doi. 10.1111/ejh.13332
- By:
- Publication type:
- Article
Reduced‐intensity conditioning allogeneic transplant with dual T‐cell depletion in myelofibrosis.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 6, p. 597, doi. 10.1111/ejh.13327
- By:
- Publication type:
- Article
Reduced intensity allogeneic stem cell transplant with anti‐thymocyte globulin and post‐transplant cyclophosphamide in acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 5, p. 510, doi. 10.1111/ejh.13321
- By:
- Publication type:
- Article
Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 5, p. 483, doi. 10.1111/ejh.13314
- By:
- Publication type:
- Article
Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 6, p. 486, doi. 10.1111/ejh.13230
- By:
- Publication type:
- Article
Outcome following second allogeneic hematopoietic cell transplantation: A single‐center experience.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 308, doi. 10.1111/ejh.13015
- By:
- Publication type:
- Article
Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo- HCT: 12-year follow-up data.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 2, p. 160, doi. 10.1111/ejh.12899
- By:
- Publication type:
- Article
No Significance of Derivative Chromosome 9 Deletion on the Clearance Kinetics of BCR/ABL Fusion Transcripts, Cytogenetic or Molecular Response, Loss of Response, or Treatment Failure to Imatinib Mesylate Therapy for Chronic Myeloid Leukemia.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 4, p. 772, doi. 10.1002/cncr.23607
- By:
- Publication type:
- Article
Cardiovascular Events After Exposure to Nilotinib in Chronic Myeloid Leukemia: Long-term Follow-up.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Post-transplant maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation harmonizing multiple therapeutic modalities including targeted therapy, immunotherapy and cellular therapy.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 1, p. 1, doi. 10.1007/s12185-023-03614-x
- By:
- Publication type:
- Article
Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category.
- Published in:
- Genes, Chromosomes & Cancer, 2013, v. 52, n. 1, p. 44, doi. 10.1002/gcc.22005
- By:
- Publication type:
- Article
Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 5, p. 392, doi. 10.1002/ajh.23955
- By:
- Publication type:
- Article
BCR/ABL level at 6 months identifies good risk CML subgroup after failing early molecular response at 3 months following imatinib therapy for CML in chronic phase.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 6, p. 626, doi. 10.1002/ajh.23707
- By:
- Publication type:
- Article
A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 10, p. 961, doi. 10.1002/ajh.23281
- By:
- Publication type:
- Article
Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 1, p. 37, doi. 10.1002/ajh.22193
- By:
- Publication type:
- Article
Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 4, p. 346, doi. 10.1002/ajh.21980
- By:
- Publication type:
- Article
Comprehensive evaluation of time-to-response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: Which parameter at which time-point does matter?
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 11, p. 856, doi. 10.1002/ajh.21850
- By:
- Publication type:
- Article
Evidence that 6q25.1 variant rs6931104 confers susceptibility to chronic myeloid leukemia through RMND1 regulation.
- Published in:
- PLoS ONE, 2019, v. 14, n. 6, p. 1, doi. 10.1371/journal.pone.0218968
- By:
- Publication type:
- Article
Next‐generation sequencing‐based analysis to assess the pattern of relapse in patients with Philadelphia‐positive acute lymphoblastic leukemia.
- Published in:
- EJHaem, 2022, v. 3, n. 4, p. 1145, doi. 10.1002/jha2.514
- By:
- Publication type:
- Article
Single cell proteogenomic sequencing identifies a relapse‐fated AML subclone carrying FLT3‐ITD with CN‐LOH at chr13q.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 426, doi. 10.1002/jha2.390
- By:
- Publication type:
- Article
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.
- Published in:
- Current Oncology, 2024, v. 31, n. 3, p. 1426, doi. 10.3390/curroncol31030108
- By:
- Publication type:
- Article
SNP Selection in Genome-Wide Association Studies via Penalized Support Vector Machine with MAX Test.
- Published in:
- Computational & Mathematical Methods in Medicine, 2013, p. 1, doi. 10.1155/2013/340678
- By:
- Publication type:
- Article